Search Everything

Find articles, journals, projects, researchers, and more

Back to Articles

The fate of the new pharmacy bill: going backwards or forwards

Authors:
Chia-Ying Lee, Xiaohan Chen, Robert J. Romanelli, Jodi B. Segal

Abstract

The United States (U.S.) Food and Drug Administration, as protectors of public health, encourages generic drug development and use so that patients can access affordable medications. The FDA, however, has limited mechanisms to encourage generic drug manufacturing.


Keywords: Generic drug Incentives U.S. Food and Drug Administration
DOI: https://doi.ms/10.00420/ms/1042/V904O/VKT | Volume: 9 | Issue: 1 | Views: 0
Download Full Text (Free)
Article Document
1 / 1
100%

Subscription Required

Your subscription has expired. Please renew your subscription to continue downloading articles and access all premium features.

  • Unlimited article downloads
  • Access to premium content
  • Priority support
  • No ads or interruptions

Upload

To download this article, you can either subscribe for unlimited downloads, or upload 0 items (articles and/or projects) to download this specific article.

Total: 0 / 0
  • Choose any combination (e.g., 2 articles + 1 project = 3 total)
  • After uploading, you can download this specific article
  • Or subscribe for unlimited downloads of all articles